BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 27.80
-0.65 (-2.28%)
Jan 21, 2026, 12:49 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.87 billion as of January 21, 2026. Its market cap has decreased by -26.10% in one year.
Market Cap
1.87B
Enterprise Value
1.19B
Revenue
244.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.80
Market Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.87B, an increase of 55.39%. That is a compound annual growth rate of 1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.87B | -3.23% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.27B |
| Vicore Pharma Holding AB | 3.12B |
| Saniona AB | 3.02B |
| Flerie AB | 2.83B |
| Egetis Therapeutics AB | 1.77B |
| Diamyd Medical AB | 1.70B |
| Cantargia AB | 1.37B |
| Genovis AB (publ.) | 1.37B |